Follow
katia mazzocco
katia mazzocco
Istituto Giannina Gaslini
Verified email at gaslini.org
Title
Cited by
Cited by
Year
Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients
I Casciano, K Mazzocco, L Boni, G Pagnan, B Banelli, G Allemanni, ...
Cell Death & Differentiation 9 (3), 246-251, 2002
2642002
Quality assessment of genetic markers used for therapy stratification
IM Ambros, J Benard, M Boavida, N Bown, H Caron, V Combaret, ...
Journal of clinical oncology 21 (11), 2077-2084, 2003
1402003
MYCN On cogene Amplification in Neuroblastom a Is Associated VVith VVorse Prognosis, Except in Stage 4s: The Italian Experience VVith 295 Children
GP Tonini, L Boni, A Pession, D Rogers
Journal of clinical oncology 15 (1), 85-93, 1997
1371997
Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors
M Łastowska, C Cullinane, S Variend, S Cotterill, N Bown, S O’Neill, ...
Journal of clinical oncology 19 (12), 3080-3090, 2001
1352001
Neuroblastoma in adolescents: the Italian experience
M Conte, S Parodi, B De Bernardi, C Milanaccio, K Mazzocco, P Angelini, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2006
1082006
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative …
G Schleiermacher, J Michon, A Ribeiro, G Pierron, V Mosseri, H Rubie, ...
British journal of cancer 105 (12), 1940-1948, 2011
1062011
Genomic amplifications and distal 6q loss: novel markers for poor survival in high-risk neuroblastoma patients
P Depuydt, V Boeva, TD Hocking, R Cannoodt, IM Ambros, PF Ambros, ...
JNCI: Journal of the National Cancer Institute 110 (10), 1084-1093, 2018
912018
Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases
C Gambini, M Conte, G Bernini, P Angelini, A Pession, P Paolucci, ...
Virchows Archiv 442, 555-562, 2003
872003
A multilocus technique for risk evaluation of patients with neuroblastoma
IM Ambros, B Brunner, G Aigner, C Bedwell, K Beiske, J Bénard, N Bown, ...
Clinical Cancer Research 17 (4), 792-804, 2011
592011
Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins
F Morandi, P Scaruffi, F Gallo, S Stigliani, S Moretti, S Bonassi, C Gambini, ...
PloS one 7 (1), e29922, 2012
572012
Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
AP Berbegall, D Bogen, U Pötschger, K Beiske, N Bown, V Combaret, ...
British journal of cancer 118 (11), 1502-1512, 2018
512018
Exosomal microRNAs from longitudinal liquid biopsies for the prediction of response to induction chemotherapy in high-risk neuroblastoma patients: a proof of concept SIOPEN study‖
M Morini, D Cangelosi, D Segalerba, D Marimpietri, F Raggi, A Castellano, ...
Cancers 11 (10), 1476, 2019
492019
Homozygous inactivation of NF1 gene in a patient with familial NF1 and disseminated neuroblastoma
P Origone, R Defferrari, K Mazzocco, CL Cunsolo, BD Bernardi, GP Tonini
American Journal of Medical Genetics Part A 118 (4), 309-313, 2003
492003
Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors
A Garaventa, L Boni, MSL Piccolo, GP Tonini, C Gambini, A Mancini, ...
Annals of Oncology 13 (6), 956-964, 2002
482002
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN …
R Defferrari, K Mazzocco, IM Ambros, PF Ambros, C Bedwell, K Beiske, ...
British journal of cancer 112 (2), 290-295, 2015
442015
Real-Time Quantitative PCR for the Measurement of MYCN Amplification in Human Neuroblastoma with the TaqMan Detection System
CC Raggi, ML Bagnoni, GP Tonini, M Maggi, G Vona, P Pinzani, ...
Clinical chemistry 45 (11), 1918-1924, 1999
431999
Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization
P Scaruffi, S Coco, F Cifuentes, D Albino, M Nair, R Defferrari, ...
Cancer genetics and cytogenetics 177 (1), 20-29, 2007
402007
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)
A Bellini, U Pötschger, V Bernard, E Lapouble, S Baulande, PF Ambros, ...
Journal of Clinical Oncology 39 (30), 3377, 2021
362021
Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells
S Coco, R Defferrari, P Scaruffi, A Cavazzana, C Di Cristofano, L Longo, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005
362005
Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients’ survival and indicate proteins targetable at onset of disease
MR Esposito, A Binatti, M Pantile, A Coppe, K Mazzocco, L Longo, ...
International journal of cancer 143 (10), 2525-2536, 2018
312018
The system can't perform the operation now. Try again later.
Articles 1–20